Skip to main content
. Author manuscript; available in PMC: 2024 Feb 15.
Published in final edited form as: Drug Saf. 2020 Feb;43(2):189–191. doi: 10.1007/s40264-019-00883-6

Figure 1.

Figure 1.

Nationally projected number of prescriptions dispensed for buprenorphine-naloxone oral products from U.S. retail pharmacies, stratified by dosage form and type of tablet packaging, 2008-2017.

Nationally projected prescription data from 2008-2017 were extracted from the IQVIA: National Prescription Audit (NPA). IQVIA NPA contains de-identified prescription level data from U.S. retail pharmacies representing 92% of the prescriptions dispensed nationally. These data are then projected to represent 100% of prescription drugs filled at retail pharmacies. Key dates include: Suboxone buprenorphine-naloxone film available in unit-dose packaging available (August 2010); first buprenorphine-naloxone tablets (Zubsolv) available in unit-dose blister packaging (July 2013).